The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
@shotter, thanks for your insights much appreciated, if you look back thru my posts you will see I've been saying this for quite a while now.
Hospitals are now preparing for the next wave, so they are at least using this time wisely.
Don't assume anything, you just end up looking like a t it
LSE virtually unreadable today.... nothings changed with NYCT since yesterday for the SP apart from the Avacta news... IMO home test declaration(on gov portal) is doomed...it's almost like self declaring that you're over the alcohol limit...of course you won't...the testing market is evolving... it's coming away from pillar 1 testing...BoJo already said that it would go into the hands of the private sector to open up the UK more, so that's what NCYT are ramping up...the private sector e.g. arenas, stadiums, venues etc... I'm sure NYCT will report once they have more meat on the bones.... one thing I can assure you, they are very busy
He rarely comments and is one of the posters I pay attention to ,look back and see what he does for a living.
Shortter, would that have been your advice to an ASOS share holder?
if you are invested for the next 10 yrs you won't be here commenting and checking on daily price.
Just admit you bought high and are in loss and hope to make money out this
AIM share is a game.
We are approaching 1m cases a day globally and still rising, yet people look at the UK (lockdown effect reduction) and assume covid is over and NCYT have peaked. It's a little shortsighted, and I for one have put my money where my mouth is on that
" but the fact remains that we are not in the govt's good books. Burnt our bridges and we will not be favoured."
Its just a contract dispute & we haven't burned any bridges with the government !
We have been chosen as a supplier in two multi billion contracts just after the sp drop?! One directly via two of Novacyt's subsidiaries (Primer Design & Microgen Bioproducts)
https://bidstats.uk/tenders/2021/W15/748945953
and the other contract via :
1-Cambridge testing centre which Novacyt is one of its two testing kits manufacturers,.
2-Excalibur healthcare
3-Queen Mary's University
https://twitter.com/NewFormsResearc/status/1384343150437797889
Agree with what you state but the fact remains that we are not in the govt's good books. Burnt our bridges and we will not be favoured. What makes an excellent company besides the product is an able management. Talk about being gold standard is futile unless you have signed contracts. A bird in hand is worth two in the bushes. Seems there is serious doubt about the bird in hand also.
Whilst losing nrly 70% of my investment isn't the nicest of things to watch. I'm holding on.
The UK last lockdown was very successful in bringing down the numbers and get things are under control.
The perception in the UK at least appears to be that the pandemic is over, job done.
I'm afraid I don't share that optimism. One only has to look away from these to see that covid is tearing through other countries at a rapid rate.
The government should now be doubling down on building up capacity for testing, ready for, as Johnson freely admits, the next wave, repairing the roof, whilst the sun shines.
Although the number of positive cases has thankfully plummeted, the volume of testing remains high, especially in the acute hospital setting.
I fear we are not out of this yet, rather the eye of the storm.
Its inevitable that a variant will emerge thats resistant to the vaccine and off we will go again.
Testing, social distancing, vaccinations and contact tracing are here for the foreseeable future.
The testing, tracing etc processes will mature and develop. Novacyt are part of this process, think global too, not just UK, AIM markets seem to focus on the here and now or with a very limited Horizon.
I'm investing for the next 10 yrs, thats my personal time frame. The share price volatility will continue at the whims of market sentiment.
I invested in nova as the company has good foundations, good products, excellent R&D.
Unless I sell now, I've not lost a penny, so will keep my powder dry and ride out these storms, they will pass.
Hard to keep the faith at the moment but good luck to us all.